An update on the recognition and treatment of autonomic symptoms in Parkinson’s disease

References

• Jost WH. Autonome Regulationsstörungen beim Parkinson-Syndrom. Fortschr Neurol Psychiatrie. 1995;63:194–205.
   PubMed Web of Science ®Google Scholar
• Jost WH, Augustis S. Severity of orthostatic hypotension in the course of Parkinson’s disease: no correlation with the duration of the disease. Parkinsonism Rel Disord. 2015;21:314–316.
   PubMed Web of Science ®Google Scholar
• Parkinson J. An essay on the shaking palsy. London: Sherwood, Neely, and Jones; 1817.
   Google Scholar
• Braak H, Rüb U, Gai WP, et al. Idiopathic Parkinson’s disease. Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm. 2003;110:517–536.
   PubMed Web of Science ®Google Scholar
• Pan-Montojo F, Anichtchik O, Dening Y, et al. Progression of Parkinson’s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One. 2010;5:e8762.
   PubMed Web of Science ®Google Scholar
• Barone P, Antonini A, Colosimo C, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord. 2009;24:1641–1649.
   PubMed Web of Science ®Google Scholar
• Duncan GW, Khoo TK, Yarnall AJ, et al. Health-related quality of life in early Parkinson’s disease: the impact of nonmotor symptoms. Mov Disord. 2014;29:195–202.
   PubMed Web of Science ®Google Scholar
• Den Hartog Jager WA, Bethlem J. The distribution of Lewy bodies in the central and autonomic nervous system in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry. 1960;23:283–290.
   PubMed Web of Science ®Google Scholar
• Adler CH, Beach TG. Neuropathological basis of nonmotor manifestations of Parkinson’s disease. Mov Disord. 2016;31:1114–1119.
   PubMed Web of Science ®Google Scholar
• Braak H, Rai DV, Bohl J, et al. Gastric a-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease related brain pathology. Neurosci Lett. 2006;396:67–72.
   PubMed Web of Science ®Google Scholar
• Fasano A, Visanji NP, Liu LW, et al. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol. 2015;14:625–639.
   PubMed Web of Science ®Google Scholar
• Jost WH, Del Tredici K, Landvogt C, et al. Importance of 123I-metaiodobenzylguanidin (MIBG) scintigraphy/SPECT for diagnosis and differential diagnostics of Parkinson syndromes. Neurodegenerative Dis. 2010;7:341–347.
   PubMed Web of Science ®Google Scholar
• Jost WH. Autonome Regulationsstörungen beim Parkinson-Syndrom. Aachen: Shaker-Verlag; 1999.
   Google Scholar
• Oka H, Toyoda C, Yogo M, et al. Cardiovascular dysautonomia in de novo Parkinson’s disease without orthostatic hypotension. Eur J Neurol. 2011 Feb;18(2):286–292.
   PubMed Web of Science ®Google Scholar
• Strano S, Fanciulli A, Rizzo M, et al. Cardiovascular dysfunction in untreated Parkinson’s disease: a multi-modality assessment. J Neurol Sci. 2016;370:251–255.
   PubMed Web of Science ®Google Scholar
• Korczyn AD. Autonomic nervous system disturbances in Parkinson’s disease. Adv Neurol. 1990;53:463–468.
   PubMedGoogle Scholar
• Allcock LM, Ullyart K, Kenny RA, et al. Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2004;75:1470–1471.
   PubMed Web of Science ®Google Scholar
• Umehara T, Nakahara A, Matsuno H, et al. Predictors of postprandial hypotension in elderly patients with de novo Parkinson’s disease. J Neural Transm (Vienna). 2016;123:1331–1339.
   PubMed Web of Science ®Google Scholar
• Oh YS, Kim JS, Chung YA, et al. Orthostatic hypotension, non-dipping and striatal dopamine in Parkinson disease. Neurol Sci. 2013;34:557–560.
   PubMed Web of Science ®Google Scholar
• Sommer S, Aral-Becher B, Jost W. Nondipping in Parkinson’s disease. Parkinson’s Disease. 2001. ID 897586. DOI:10.4061/2011/897586
   Web of Science ®Google Scholar
• Storch A, Schneider CB, Wolz M, et al. Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology. 2013;80:800–809.
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Ellis C, Love-Jones S, et al. Postprandial hypotension and parkinsonian state in Parkinson’s disease. Mov Disord. 1997;12:877–884.
   PubMed Web of Science ®Google Scholar
• Thomaides T, Karapanayiotides T, Zoukos Y, et al. Gastric emptying after semi-solid food in multiple system atrophy and Parkinson’s disease. J Neurol. 2005;252:1055–1059.
   PubMed Web of Science ®Google Scholar
• Goldstein DS. Orthostatic hypotension as an early finding in Parkinson’s disease. Clin Autonom Res. 2006;16:46–54.
   PubMed Web of Science ®Google Scholar
• Braak H, Del Tredici K, Bratzke H, et al. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease. J Neurol. 2002;249(S3):1–5.
   PubMed Web of Science ®Google Scholar
• Low PA, Singer W. Management of neurogenic orthostatic hypotension: an update. Lancet Neurol. 2008;7:451–458.
   PubMed Web of Science ®Google Scholar
• Schoffer KL, Henderson RD, O’Maley K, et al. Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson’s disease. Mov Disord. 2007;22:1543–1549.
   PubMed Web of Science ®Google Scholar
• Hauser RA, Isaacson S, Lisk JP, et al. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson’s disease (nOH306B). Mov Disord. 2015;30:646–654.
   PubMed Web of Science ®Google Scholar
• Stemper B, Beric A, Welsch G, et al. Deep brain stimulation improves orthostatic regulation of patients with Parkinson disease. Neurology. 2006;67:1781–1785.
   PubMed Web of Science ®Google Scholar
• Tateno F, Sakakibara R, Nagao T, et al. Deep brain stimulation ameliorates postural hypotension in Parkinson’s disease. J Am Geriatr Soc. 2015 Oct;63(10):2186–2189.
   PubMed Web of Science ®Google Scholar
• Augustis S, Saferis V, Jost WH. Autonomic disturbances including impaired hand thermoregulation in multiple system atrophy and Parkinson’s disease. J Neural Transm. 2017. DOI:10.1007/s00702-016-1665-8
   PubMed Web of Science ®Google Scholar
• Aminoff MJ, Wilcox CS. Assessment of autonomic function in patients with a Parkinsonian syndrome. Br Med J. 1971;4(5779):80–84.
   PubMed Web of Science ®Google Scholar
• Taly AB, Muthane UB. Involvement of peripheral nervous system in juvenile Parkinson’s disease. Acta Neurol Scand. 1992;85:272–275.
   PubMed Web of Science ®Google Scholar
• Pursiainen V, Haapaniemi TH, Korpelainen JT, et al. Sweating in Parkinsonian patients with wearing-off. Mov Disord. 2007;22:828–832.
   PubMed Web of Science ®Google Scholar
• Witjas T, Kaphan E, Azulay JP, et al. (2002) Nonmotor fluctuations in Parkinson’s disease: frequent and disabling. Neurology. 2002;59(3):408–413.
   PubMed Web of Science ®Google Scholar
• Arbouw ME, Movig KL, Koopmann M, et al. Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial. Neurology. 2010;74:1203–1207.
   PubMed Web of Science ®Google Scholar
• Seppi K, Weintraub D, Coelho M, et al. The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson’s disease. Mov Disord. 2011;26(S3):S42–80.
   PubMed Web of Science ®Google Scholar
• Zesiewicz TA, Sullivan KL, Arnulf I, et al. Practice parameter: treatment of nonmotor symptoms of Parkinson disease: report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2010; 74: 924–931.
   PubMed Web of Science ®Google Scholar
• Jost WH. Urological problems in Parkinson’s disease: clinical aspects. J Neural Transm. 2013;120:587–591.
   PubMed Web of Science ®Google Scholar
• Sakakibara R, Uchiyama T, Yamanishi T, et al. Genitourinary dysfunction in Parkinson’s disease. Mov Disord. 2010;25:2–12.
   PubMed Web of Science ®Google Scholar
• Andersen JT, Hebjørn S, Frimodt-Møller C, et al. Disturbances of micturition in Parkinson’s disease. Acta Neurol Scand. 1976;53:161–170.
   PubMed Web of Science ®Google Scholar
• Raz S. Parkinsonism and neurogenic bladder. Urol Res. 1976;4:133–138.
   PubMedGoogle Scholar
• Winge K, Werdelin LM, Nielsen KK, et al. Effects of dopaminergic treatment on bladder function in Parkinson’s disease. Neurourol Urodynam. 2004;23:689–696.
   PubMed Web of Science ®Google Scholar
• Lemack GE, Dewey RB, Roehrborn CR, et al. Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson’s disease. Urology. 2000;56:250–254.
   PubMed Web of Science ®Google Scholar
• Mock S, Osborn DJ, Brown ET, et al. The impact of pallidal and subthalamic deep brain stimulation on urologic function in Parkinson’s disease. Neuromodulation. 2016;19:717–723.
   PubMed Web of Science ®Google Scholar
• Brusa L, Petta F, Pisani A, et al. Acute vs chronic effects of L-dopa on bladder function in patients with mild Parkinson disease. Neurology. 2007;68:1455–1459.
   PubMed Web of Science ®Google Scholar
• Galloway NT. Urethral sphincter abnormalities in Parkinsonism. Br J Urol. 1983;55:691–693.
   PubMedGoogle Scholar
• Sakakibara R, Panicker J, Finazzi-Agro E, et al. A guideline for the management of bladder dysfunction in Parkinson’s disease and other gait disorders. Neurourol Urodyn. 2016;35(5):551–563.
   PubMed Web of Science ®Google Scholar
• Varanda S, Ribeiro da Silva J, Costa AS, et al. Sexual dysfunction in women with Parkinson’s disease. Mov Disord. 2016;31(11):1685–1693.
   PubMed Web of Science ®Google Scholar
• Eadie MJ, Tyrer JH. Alimentary disorder in parkinsonism. Australas Ann Med. 1965;14:13–22.
   PubMedGoogle Scholar
• Chou KL, Evatt M, Hinson V, et al. Sialorrhea in Parkinson’s disease: a review. Mov Disord. 2007;16:2306–2313.
   Web of Science ®Google Scholar
• Molloy L. Treatment of sialorrhoea in patients with Parkinson’s disease: best current evidence. Curr Opinion Neurol. 2007;20:493–498.
   PubMed Web of Science ®Google Scholar
• Jost WH. The option of sonographic guidance in botulinum toxin injection for drooling in Parkinson’s disease. J Neural Transm. 2015;123:51–55.
   PubMed Web of Science ®Google Scholar
• Bushmann M, Dobmeyer SM, Leeker L, et al. Swallowing abnormalities and their response to treatment in Parkinson’s Disease. Neurology. 1989;39:1309–1314.
   PubMed Web of Science ®Google Scholar
• Edwards L, Quigley EMM, Hofman R, et al. Gastrointestinal symptoms in Parkinson disease: 18-month follow-up study. Mov Disord. 1993;8:83–86.
   PubMed Web of Science ®Google Scholar
• Ertekin C, Tarlaci S, Aydogdu I, et al. Electrophysiological evaluation of pharyngeal phase of swallowing in patients with Parkinson’s disease. Mov Disord. 2002;17:942–949.
   PubMed Web of Science ®Google Scholar
• Palmer ED. Dysphagia in parkinsonism. JAMA. 1974;229:1349.
   PubMed Web of Science ®Google Scholar
• Kurlan R, Rubin AJ, Miller C, et al. Continuous intraduodenal infusion of levodopa for resistant on-off fluctuations in parkinsonism. Ann Neurol. 1985;18:139.
   Web of Science ®Google Scholar
• Parkes JD. Domperidone and Parkinson’s disease. Clin Neuropharmacol. 1986;9:517–532.
   PubMed Web of Science ®Google Scholar
• Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson’s disease. Neurology. 2001;57:456–464.
   PubMed Web of Science ®Google Scholar
• Svensson E, Henderson VW, Borghammer P, et al. Constipation and risk of Parkinson’s disease: a Danish population-based cohort study. Parkinsonism Relat Disord. 2016;28:18–22.
   PubMed Web of Science ®Google Scholar
• Knudsen K, Krogh K, Østergaard K, et al. Constipation in Parkinson’s disease: subjective symptoms, objective markers, and new perspectives. Mov Disord. 2017;32:94–105.
   PubMed Web of Science ®Google Scholar
• Sampson TR, Debelius JW, Thron T, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease. Cell. 2017;167:1469–1480.
   Web of Science ®Google Scholar
• Kaye J, Gage H, Kimber A, et al. Excess burden of constipation in Parkinson’s disease: a pilot study. Mov Disord. 2006;21:1270–1273.
   PubMed Web of Science ®Google Scholar
• Zangaglia R, Martignoni E, Glorioso M, et al. Macrogol for the treatment of constipation in Parkinson’s disease. A randomized placebo-controlled study. Mov Disord. 2007;22:1239–1244.
   PubMed Web of Science ®Google Scholar